Therapeutic management of allergic diseases

References

• Abe, Y., Ogino, S., Irifune, M., Imamura, I., Fukui, H., Wada, H., et al. (1993). Histamine content, synthesis, and degradation in human nasal mucosa. Clin Exp Allergy 23:132–136.
   PubMed Web of Science ®Google Scholar
• Abernethy, D.R., Barbey, J.T., Franc, J., Brown, K.S., Feirrera, I., Ford, N., Salazar, D.E. (2001). Loratadine and terfenadine interaction with nefazodone: both antihistamines are associated with QTc prolongation. Clin Pharmacol Ther 69:96–103.
   PubMed Web of Science ®Google Scholar
• Adcock, I.M., Nasuhara, Y., Stevens, D.A., Barnes, P.J. (1999). Ligand-Induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. Br J Pharmacol 127:1003–1011.
   PubMed Web of Science ®Google Scholar
• Adinoff, A.D., Hollister, J.R. (1983). Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309:265–268.
   PubMed Web of Science ®Google Scholar
• Agertoft, L., Pedersen, S. (1994). Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 88:373–381.
   PubMed Web of Science ®Google Scholar
• Agertoft, L., Pedersen, S. (2000). Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 343:1064–1069.
   PubMed Web of Science ®Google Scholar
• Ahmad, N., Anderson, M., Younus, F. (2006). Does steroid exposure adversely affect the outcome of subacute bacterial endocarditis? Report of two cases. Scand J Infect Dis 38:136–139.
   PubMed Web of Science ®Google Scholar
• Aljazaf, K., Hale, T.W., Ilett, K.F., et al. (2003). Pseudoephedrine: effects on milk production in women and estimation of infant exposure via breastmilk. Br J Clin Pharmacol 56:18–24.
   PubMed Web of Science ®Google Scholar
• Allen, D.B. (2000a). Do intranasal corticosteroids affect childhood growth? Allergy 55(Suppl 62):15–18.
   PubMedGoogle Scholar
• Allen, D.B. (2000b). Systemic effects of intranasal steroids: an endocrinologist’s perspective. J Allergy Clin Immunol 106:S179–S190.
   PubMed Web of Science ®Google Scholar
• Allen, D.B., Mullen, M., Mullen, B. (1994). A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 93:967–976.
   PubMed Web of Science ®Google Scholar
• Allen, M.B., Ray, S.G., Leitch, A.G., Dhillon, B., Cullen, B. (1989). Steroid aerosols and cataract formation. BMJ 299:432–433.
   PubMed Web of Science ®Google Scholar
• Andersson, K.E., Persson, C.G. (1980). Extrapulmonary effects of theophylline. Eur J Respir Dis Suppl 109:17–28.
   PubMedGoogle Scholar
• Andersson, M., Lindqvist, N., Svensson, C., Ek, L., Pipkorn, U. (1993). Dry powder inhalation of budesonide in allergic rhinitis. Clin Otolaryngol Allied Sci 18:30–33.
   PubMed Web of Science ®Google Scholar
• Anderson, P. (2005). Patient preference for and satisfaction with inhaler devices. Eur Respir Rev 14:109–116.
   Google Scholar
• Anthes, J.C., Gilchrest, H., Richard, C., Eckel, S., Hesk, D., West, R.E., Jr,, et al. (2002). Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor. Eur J Pharmacol 449:229–237.
   PubMed Web of Science ®Google Scholar
• Atkinson, M.J., Sinha, A., Hass, S.L., Colman, S.S., Kumar, R.N., Brod, M., et al. (2004). Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2:12–24.
   PubMedGoogle Scholar
• Autio, P., Karjalainen, J., Risteli, L., Risteli, J., Kiistala, U., Oikarinen, A. (1996). Effects of an inhaled steroid (budesonide) on skin collagen synthesis of asthma patients in vivo. Am J Respir Crit Care Med 153:1172–1175.
   PubMed Web of Science ®Google Scholar
• Averbeck, M., Gebhardt, C., Emmrich, F., et al. (2007). Immunologic principles of allergic disease. Journal der Deutschen Dermatologischen Gesellschaft 5:1015–1028.
   PubMedGoogle Scholar
• Bachert, C., Bousquet, J., Canonica, G.W., Durham, S.R., Klimek, L., Mullol, J., et al., for, the XPERT Study Group. (2004). Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 114:838–844.
   PubMed Web of Science ®Google Scholar
• Bakker, R.A., Jongejan, A., Sansuk, K., Hacksell, U., Timmerman, H., Brann, M.R., et al. (2008). Constitutively active mutants of the histamine H1 receptor suggest a conserved hydrophobic asparagine-cage that constrains the activation of class A G protein–coupled receptors. Mol Pharmacol 73:94–103.
   PubMed Web of Science ®Google Scholar
• Baltes, E., Coupez, R., Giezek, H., Voss, G., Meyerhoff, C., Strolin, B.M. (2001). Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers. Fundam Clin Pharmacol 15:269–277.
   PubMed Web of Science ®Google Scholar
• Barnes, N. (1998). Relative safety and efficacy of inhaled corticosteroids. J Allergy Clin Immunol 101:S460–S464.
   PubMed Web of Science ®Google Scholar
• Barnes, N.C., Hallett, C., Harris, T.A. (1998a). Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med 92:95–104.
   PubMed Web of Science ®Google Scholar
• Barnes, N.C., Marone, G., Di Maria, G.U., Visser, S., Utama, I., Payne, S.L. (1993). A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group. Eur Respir J 6:877–885.
   PubMed Web of Science ®Google Scholar
• Barnes, P.J. (2000). The pharmacological properties of tiotropium. Chest 117:S63–S66.
   PubMed Web of Science ®Google Scholar
• Barnes, P.J., Pedersen, S. (1993). Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis (4 pt 2) 148:S1–S26 Review.
   PubMed Web of Science ®Google Scholar
• Barnes, P.J., Pedersen, S., Busse, W.W. (1998b). Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 157:S1–S53.
   PubMed Web of Science ®Google Scholar
• Barnes, P.J. (2006). Corticosteroids: the drugs to beat. Eur J Pharmacol 533:2–14.
   PubMed Web of Science ®Google Scholar
• Baroody, F.M., Ford, S., Proud, D., Kagey-Sobotka, A., Lichtenstein, L., Naclerio, R.M. (1999). Relationship between histamine and physiological changes during the early response to nasal antigen provocation. J Appl Physiol 86:659–668.
   PubMed Web of Science ®Google Scholar
• Beakes, D.E. (1997). The use of anticholinergics in asthma. J Asthma 34:357–368.
   PubMed Web of Science ®Google Scholar
• Beasley, R., Burgess, C., Pearce, N., Woodman, K., Crane, J. (1994). Confounding by severity does not explain the association between fenoterol and asthma death. Clin Exp Allergy 24:660–668.
   PubMed Web of Science ®Google Scholar
• Beasley, R., Pearce, N., Crane, J., Burgess, C. (1999). Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol 104:S18–S30.
   PubMed Web of Science ®Google Scholar
• Bender, B., Milgrom, H. (1992). Theophylline-induced behavior change in children. An objective evaluation of parents’ perceptions. JAMA 267:2621–2624.
   PubMed Web of Science ®Google Scholar
• Benson, R.L., Perlman, F. (1948). Clinical effects of epinephrine by inhalation; a survey. J Allergy 19:129–140.
   PubMedGoogle Scholar
• Benton, R.E., Honig, P.K., Zamani, K., Cantilena, L.R., Woosley, R.L. (1996). Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram. Clin Pharmacol Ther 59:383–388.
   PubMed Web of Science ®Google Scholar
• Bielory, L. (2002). Update on ocular allergy treatment. Expert Opin Pharmacother 3:541–553.
   PubMedGoogle Scholar
• Bielory, L., Blaiss, M., Fineman, S.M., Ledford, D.K., Lieberman, P., Simons, F.E., et al. (2006). Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 96:514–525.
   PubMed Web of Science ®Google Scholar
• Black, R.A., Hill, D.A. (2003). Over-the-counter medications in pregnancy. Am Fam Physician 67:2517–2524.
   PubMed Web of Science ®Google Scholar
• Blaiss, M.S. (2007). Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis. Allergy Asthma Proc 28:145–152.
   PubMed Web of Science ®Google Scholar
• Bond, R.A., Ijzerman, A P. (2006). Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol Sci 27:92–96.
   PubMed Web of Science ®Google Scholar
• Bousquet, J., Van Cauwenberge, P., Kalthaiev, N., ARIA, Workshop Group, World, Health Organization. (2001). Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108:S147–S334.
   PubMed Web of Science ®Google Scholar
• Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A., et al.; World, Health Organization; GA(2)LEN,; AllerGen. (2008). Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN, and AllerGen). Allergy 63(Suppl 86):8–160.
   PubMed Web of Science ®Google Scholar
• Bousquet, J., Van Cauwenberge, P., Bachert, C., Canonica, G.W., Demoly, P., Durham, S.R., Fokkens, W., Lockey, R., Meltzer, E.O., Mullol, J., Naclerio, R.M., Price, D., Simsons, F.E., Vignola, A.M., Warner, JO; European Academy of Allergy and Clinical Immunology(EAACI); Allergic Rhinitis and its Impact on Asthma (ARIA). (2004). Requirements for medications commonly used in the treatment for allergic rhinitis EAACI, ARIA. Rev. Fr Allergol Immunol Clin; 44: 177–182.
   Google Scholar
• Bourne, H.R., Roberts, J.M. (1995). Drug receptors and pharmacodynamics. In: Katzung, B.G. (Ed.), Basic and Clinical Pharmacology (pp 9–32 ). Stamford, Connecticut, USA: Appleton and Lange.
   Google Scholar
• Boxenbaum, H. (1999). Human in vivo competitive inhibition of P450 substrates: increased plasma concentrations as a function of hepatic extraction ratio and percent inhibition. J Pharm Pharmaceut Sci 2:89–91.
   PubMed Web of Science ®Google Scholar
• Brogden, R.N., Sorkin, E.M. (1993). Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma. Drugs 45:693–715.
   PubMed Web of Science ®Google Scholar
• Bryson, H.M., Faulds, D. (1992). Intranasal fluticasone propionate A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. Drugs 43:760–773.
   PubMed Web of Science ®Google Scholar
• Burton, C., Worth, A. (2008). UK Resuscitation Council guidelines on emergency treatment of anaphylactic reactions: a primary care perspective. Prim Care Respir J 17:60–61.
   PubMedGoogle Scholar
• Capra, V., Thompson, M.D., Sala, A., Cole, D.E., Folco, G., Rovati, G.E. (2007). Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends. Med Res Rev 27:469–527.
   PubMed Web of Science ®Google Scholar
• Cheung, D., Timmers, M.C., Zwinderman, A.H., Bel, E.H., Dijkman, J.H., Sterk, P.J. (1992). Long-term effects of a long-acting beta-2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 327:1198–1203.
   PubMed Web of Science ®Google Scholar
• Cheung, D., Wever, A.M., de, G.J., de, G.C., Steen, H., Sterk, P.J. (1998). Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo. Am J Respir Crit Care Med 158:792–796.
   PubMed Web of Science ®Google Scholar
• Costa, T. and Herz, A. (1989). Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci U S A 86:7321–7325.
   PubMed Web of Science ®Google Scholar
• Coopman, S., Degreef, H., Dooms-Goossens, A. (1989). Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol 121:27–34.
   PubMed Web of Science ®Google Scholar
• Corrado, O.J., Gomez, E., Baldwin, D.L., Clague, J.E., Davies, R.J. (1987). The effect of nedocromil sodium on nasal provocation with allergen. J Allergy Clin Immunol 80:218–222.
   PubMed Web of Science ®Google Scholar
• Craft, T.M. (1986). Torsade de pointes after astemizole overdose. Br Med J (Clin Res Ed) 292:660.
   PubMed Web of Science ®Google Scholar
• Crane, J., Pearce, N., Flatt, A., Burgess, C., Jackson, R., Kwong, T., et al. (1989). Prescribed fenoterol and death from asthma in New Zealand, 1981–1983: case-control study. 1:917–922.
   Google Scholar
• Czeizel, A.E., Gidai, J., Petik, D., Timmermann, G., Puho, E.H. (2008). Self-poisoning during pregnancy as a model for teratogenic risk estimation of drugs. Toxicol Industr Health 24(1–2):11–28.
   PubMed Web of Science ®Google Scholar
• Czock, D., Keller, F., Rasche, F.M., et al. (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44:61–98.
   PubMed Web of Science ®Google Scholar
• Daley-Yates, P.T., Kunka, R.L., Yin, Y., Andrews, S.M., Callejas, S., Ng, C. (2004). Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays. Eur J Clin Pharmacol 60:265–268.
   PubMed Web of Science ®Google Scholar
• Davis, R., Whittington, R., Bryson, H.M. (1997). Nefazodone A review of its pharmacology and clinical efficacy in the management of major depression. Drugs 53:608–636.
   PubMed Web of Science ®Google Scholar
• Dekhuijzen, R., Koopmans, P.P. (2002). Pharmacokinetic profile of zafirlukast. Clin Pharmacokinet 41:105–114.
   PubMed Web of Science ®Google Scholar
• Demoly, P., Piette, V., Daures, J.P. (2003). Treatment of allergic rhinitis during pregnancy. Drugs 63:1813–1820.
   PubMed Web of Science ®Google Scholar
• Deniz, Y.M. and Gupta, N. (2005) Safety and tolerability of omalizumab (Xolair), a recombinant humanized monoclonal anti-IgE antibody. Clin Rev Allergy Immunol 29:31–48.
   PubMed Web of Science ®Google Scholar
• Derendorf, H. and Meltzer, E.O. (2008). Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy 63:1292–1300.
   PubMed Web of Science ®Google Scholar
• Dollery, C. (1999). Zafirlukast. In: Dollery, C. (Ed.), Therapeutic Drugs, 2nd ed. Vol. 2 (Z1–Z6 ). Churchill Livingstone, Edinburgh.
   Google Scholar
• Donnelly, A., and Casale, T.B. (1993). Nedocromil sodium is rapidly effective in the therapy of seasonal allergic rhinitis. J Allergy Clin Immunol 91:997–1004.
   PubMed Web of Science ®Google Scholar
• Dunn, C., Gauthier, M., and Gaudreault, P. (1993). Coma in a neonate following single intranasal dose of xylometazoline. Eur J Pediatr 152:541.
   PubMed Web of Science ®Google Scholar
• Dupre, D.J., Le Gouill, C., Gingras, D., Rola-Pleszczynski, M., and Stankova, J. (2004). Inverse Agonist Activity of Selected Ligands of the Cysteinyl-Leukotriene Receptor 1. J Pharmacol Exp Ther 309: pp 102–108.
   PubMed Web of Science ®Google Scholar
• EFA (1999). European declaration on allergy and asthma prevention. EFA Publications, Brussels.
   Google Scholar
• EMEA (2008). Guidelines on the clinical development of products for specific immunotherapy for the treatment of allergic diseases. Doc Ref CHMP/EWP/18504/2006. EMEA publications, London. Available at: http://www.emea.europa.eu/pdfs/human/ewp/1850406enfin.pdf (access date Jan 2009).
   Google Scholar
• Endre, L. (2007). [The prompt effect of emedastine eye drop and the safety of its permanent use in children suffering from acute seasonal allergic conjunctivitis]. Orv Hetil 148:251–254.
   PubMedGoogle Scholar
• Felix Toledo, R., Negro Alvarez, J.M., Miralles Lopez, JC. (2002). Omalizumab. A review of the new treatment of allergic asthma and seasonal allergic rhinitis. Allergol Immunopathol (Madr) 30:94–99.
   PubMedGoogle Scholar
• Finney, A., Rushton, C. (2007). Recognition and management of patients with anaphylaxis. Nurs Stand 21:50–57.
   PubMedGoogle Scholar
• Fokkens, W.J., Godthelp, T., Holm, A.F., Klein-Jan, A. (1998). Local corticosteroid treatment: the effect on cells and cytokines in nasal allergic inflammation. Am J Rhinol 12:21–26.
   PubMedGoogle Scholar
• Foreman, J.C., Pearce, F.L. (1988). Cromolyn. In: Middleton, Jr, E., Reed, C.E., Ellis, E.F., Adkinson, Jr, N.F., Yunginger, J.W. eds. Allergy principles and practice 3rd edn. St Louis, Missouri: CV Mosby (pp 766–81 ).
   Google Scholar
• Franco, J., Artes, M.J. (1999). Pulmonary eosinophilia associated with montelukast. Thorax 54:558–560.
   PubMed Web of Science ®Google Scholar
• Geddes, D.M. (1992). Inhaled corticosteroids: benefits and risks. Thorax 47:404–407.
   PubMed Web of Science ®Google Scholar
• Ghanchi, F. (1993). Young patients on inhaled steroids and cataract. Lancet 342:1306–1307.
   PubMed Web of Science ®Google Scholar
• Gilbert, C.G., Mazzotta, P., Loebstein, R., Koren, G. (2005). Fetal safety of drugs used in the treatment of allergic rhinitis—a critical review. Drug Saf 28:707–719.
   PubMed Web of Science ®Google Scholar
• Gillard, M., Chatelain, P. (2006). Changes in PH differently affect the binding properties of histamine H1 receptor antagonists. Eur J Pharmacol 530:205–214.
   PubMed Web of Science ®Google Scholar
• Gillard, M., Christophe, B., Wels, B., Peck, M., Massingham, R., Chatelain, P. (2003). H1 antagonists: receptor affinity versus selectivity. Inflamm Res 52:S49–S50.
   PubMed Web of Science ®Google Scholar
• Gillard, M., Van Der Perren, C., Massingham, R., Chatelain, P. (2002a). Binding characteristics of [3H]levocetirizine to cloned human H1-histamine-receptors expressed in CHO cells. Inflamm Res 51(Suppl 1):S77–S78.
   PubMedGoogle Scholar
• Gillard, M., Van Der Perren, C., Moguilevsky, N., Massingham, R., Chatelain, P. (2002b). Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194). Mol Pharmacol 61:391–399.
   PubMed Web of Science ®Google Scholar
• Gillisen, A., Lecheler, C. (2004). [Bronchial asthma: a comparison of the doctor’s assessment and the patient’s opinion]. Dtsch Med Wochenschr 129:484–489.
   PubMed Web of Science ®Google Scholar
• Gonzalez, J.P., Brogden, R.N. (1987). Nedocromil sodium. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease. Drugs 34:560–577.
   PubMed Web of Science ®Google Scholar
• Grainger, J., Woodman, K., Pearce, N., Crane, J., Burgess, C., Keane, A., et al. (1991). Prescribed fenoterol and death from asthma in New Zealand, 1981–1987: a further case-control study. Thorax 46:105–111.
   PubMed Web of Science ®Google Scholar
• Granneman, G.R., Braeckman, R.A., Locke, C.S., Cavanaugh, J.H., Dubé, L.M., Awni, W.M. (1995). Effect of zileuton on theophylline pharmacokinetics. Clin Pharmacokinet 29(Suppl 2):77–83.
   PubMedGoogle Scholar
• Green, R.L., Vayonis, A.G. (1999). Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment. Lancet 353:725–726.
   PubMed Web of Science ®Google Scholar
• Greiner, A.N., Meltzer, E.O. (2006). Pharmacologic rationale for treating allergic and nonallergic rhinitis. J Allergy Clin Immunol 118:985–998.
   PubMed Web of Science ®Google Scholar
• Grootendorst, D.C., Rabe, K.F. (2002). Selective phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol 2:61–67.
   PubMed Web of Science ®Google Scholar
• Gross, N.J. (1988). The use of anticholinergic agents in the treatment of airways disease. Clin Chest Med 9:591–598.
   PubMed Web of Science ®Google Scholar
• Gross, N.J., Skorodin, M.S. (1984). Anticholinergic, antimuscarinic bronchodilators. Am Rev Respir Dis 129:856–870.
   PubMed Web of Science ®Google Scholar
• Harding, S.M. (1990). The human pharmacology of fluticasone propionate. Respir Med 84(Suppl A):25–29.
   PubMedGoogle Scholar
• Harrold, L.R., Andrade, S.E., Go, A.S., Buist, A.S., Eisner, M., Vollmer, W.M., et al. (2005). Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol 32:1076–1080.
   PubMed Web of Science ®Google Scholar
• Harvey, J.E., Tattersfield, A.E. (1982). Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax 37:280–287.
   PubMed Web of Science ®Google Scholar
• Hashizume, T., Imaoka, S., Mise, M., Terauchi, Y., Fujii, T., Miyazaki, H., et al. (2002). Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J Pharmacol Exp Ther 300:298–304.
   PubMed Web of Science ®Google Scholar
• Haynes, R.B., Taylor, D.W., Sackett, D.L. (1979). Compliance in Health Care. Baltimore, Maryland, USA: Johns Hopkins University Press.
   Google Scholar
• Helliwell, M., Berry, D. (1979). Theophylline poisoning in adults. Br Med J 2:1114.
   PubMed Web of Science ®Google Scholar
• Hendeles, L., Sorkness, C.A. (2007). Anti-immunoglobulin E therapy with omalizumab for asthma. Ann Pharmacother 41:1397–1410.
   PubMed Web of Science ®Google Scholar
• Hendeles, L., Weinberger, M., Johnson, G. (1978). Monitoring serum theophylline levels. Clin Pharmacokinet 3:294–312.
   PubMed Web of Science ®Google Scholar
• Heuck, C., Heickendorff, L., Wolthers, O.D. (2000). A randomised, controlled trial of short-term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide. Arch Dis Child 83:334–339.
   PubMed Web of Science ®Google Scholar
• Heuck, C., Wolthers, O.D., Hansen, M., Kollerup, G. (1997). Short-term growth and collagen turnover in asthmatic adolescents treated with the inhaled glucocorticoid budesonide. Steroids 62:659–664.
   PubMed Web of Science ®Google Scholar
• Heuck, C., Wolthers, O.D., Kollerup, G., Hansen, M., Teisner, B. (1998). Adverse effects of inhaled budesonide (800 micrograms) on growth and collagen turnover in children with asthma: a double-blind comparison of once-daily versus twice-daily administration. J Pediatr 133:608–612.
   PubMed Web of Science ®Google Scholar
• Heykants, J., Van Peer, A., Van de Veldem, V., Snoeck, E., Meuldermans, W., Woestenborghs, R. (1995). The pharmacokinetic properties of topical levocabastine. Clin Pharmacokinet 29:221–230.
   PubMed Web of Science ®Google Scholar
• Hochhaus, G. (2008). Pharmacokinetic/pharmacodynamic profile of mometasone furoate nasal spray: potential effects on clinical safety and efficacy. Clin Ther 30:1–13.
   PubMed Web of Science ®Google Scholar
• Holgate, S.T. (2000). The role of mast cells and basophils in inflammation. Clin Exp Allergy 30(Suppl 1):28–32.
   PubMedGoogle Scholar
• Holgate, S.T., Canonica, G.W., Simons, F.E.R., Taglialatela, M., Tharp, M., Timmerman, H., et al. (2003). Consensus group on new- generation antihistamines (CONGA): present status and recommendations. Clin Exp Allergy 33:1305–1324.
   PubMed Web of Science ®Google Scholar
• Holgate, S.T., Polosa, R. (2008). Treatment strategies for allergy and asthma. Nat Rev Immunol 8:218–230.
   PubMed Web of Science ®Google Scholar
• Honig, P.K., Woosley, R.L., Zamani, K., Conner, D.P., Cantilena, L.R.,, Jr. (1992). Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 52:231–238.
   PubMed Web of Science ®Google Scholar
• Hopp, R.J., Degan, J.A., Biven, R.E., Kinberg, K., Gallagher, G.C. (1995). Longitudinal assessment of bone mineral density in children with chronic asthma. Ann Allergy Asthma Immunol 75:143–148.
   PubMed Web of Science ®Google Scholar
• Hosker, H.S., Tuggey, J.M. (2001). Montelukast and Churg-Strauss syndrome. Thorax 56:244.
   PubMedGoogle Scholar
• Howarth, P.H., Salagean, M., Dokic, D. (2000). Allergic rhinitis: not purely a histamine-related disease. Allergy 55(Suppl 64):7–16.
   PubMedGoogle Scholar
• Israel, E., Banerjee, T.R., Fitzmaurice, G.M., Kotlov, T.V., LaHive, K., LeBoff, M.S. (2001). Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 345:941–947.
   PubMed Web of Science ®Google Scholar
• Iriyoshi, N., Takeuchi, K., Yuta, A., Ukai, K., Sakakura, Y. (1996). Increased expression of histamine H1 receptor MRNA in allergic rhinitis. Clin Exp Allergy 26:379–385.
   PubMed Web of Science ®Google Scholar
• Iwasaki, E., Yamaura, M., Baba, M. (1993). [Assessment of the amount of drug deposited in the lungs of asthmatic children using disodium cromoglycate as the marker]. Arerugi 42:907–913.
   PubMedGoogle Scholar
• Jaakkola, T., Backman, J.T., Neuvonen, M., Niemi, M., Neuvonen, P.J. (2006). Montelukast and zafirlukast do not affect the pharmacokinetics of the CYP2C8 substrate pioglitazone. Eur J Clin Pharmacol 62:503–509.
   PubMed Web of Science ®Google Scholar
• James, I.G., Campbell, L.M., Harrison, J.M., Fell, P.J., Ellers-Lenz, B., Petzold, U. (2003). Comparison of the efficacy and tolerability of topically administered azelastine, sodium cromoglycate, and placebo in the treatment of seasonal allergic conjunctivitis and rhino- conjunctivitis. Curr Med Res Opin 19:313–320.
   PubMed Web of Science ®Google Scholar
• Juniper, E.F., Kline, P.A., Hargreave, F.E., Dolovich, J. (1989). Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 83:627–633.
   PubMed Web of Science ®Google Scholar
• Juniper, E.F., Stahl, E., Doty, R.L., Simons, F.E.R., Allen, D.B., Howarth, P. (2005). Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol 115:S390–S413.
   PubMedGoogle Scholar
• Kaiser, H.B., Findlay, S.R., Georgitis, J.W., Grossman, J., Ratner, P.H., Tinkelman, D.G., et al. (1998). The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis. Allergy Asthma Proc 19:23–29.
   PubMed Web of Science ®Google Scholar
• Kallstrom, B.L., Sjoberg, J., Waldeck, B. (1994). The interaction between salmeterol and beta-2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro. Br J Pharmacol 113:687–692.
   PubMed Web of Science ®Google Scholar
• Kaulbach, H.C., Igarashi, Y., Mullol, J., White, M.V., Kaliner, M.A. (1992). Effects of nedocromil sodium on allergen-induced rhinitis in humans. J Allergy Clin Immunol 89:599–610.
   PubMed Web of Science ®Google Scholar
• Kelly, H.W., Strunk, R.C., Donithan, M., Bloomberg, G.R., McWilliams, B.C., Szefler, S. (2003). Growth and bone density in children with mild-moderate asthma: a cross-sectional study in children entering the Childhood Asthma Management Program (CAMP). J Pediatr 142:286–291.
   PubMed Web of Science ®Google Scholar
• Kemp, J.P., Osur, S., Shrewsbury, S.B., Herje, N.E., Duke, S.P., Harding, S.M., et al. (2004). Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 79:458–466.
   PubMed Web of Science ®Google Scholar
• Kemp, S.F., Lockey, R.F., Simons, F.E., World, Allergy Organization ad hoc Committee on Epinephrine in Anaphylaxis. (2008). Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 63:1061–1070.
   PubMed Web of Science ®Google Scholar
• Kenakin, T. (2004a). Efficacy as a vector: the relative prevalence and paucity of inverse agonism. Mol Pharmacol 65:2–11.
   PubMed Web of Science ®Google Scholar
• Kenakin, T. (2004b). Principles: receptor theory in pharmacology. Trends Pharmacol Sci 25:186–192.
   PubMed Web of Science ®Google Scholar
• Kenakin, T., Jenkinson, S., Watson, C. (2006). Determining the potency and molecular mechanism of action of insurmountable antagonists. J Pharmacol Exp Ther 319:710–723.
   PubMed Web of Science ®Google Scholar
• Kerstjens, H.A., Postma, D.S., van Doormaal, J.J., van Zanten, A.K., Brand, P.L., Dekhuijzen, P.N., et al. (1994). Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group. Thorax 49:652–656.
   PubMed Web of Science ®Google Scholar
• Kim, K.A., Park, P.W., Kim, K.R., Park, J.Y. (2006). Effect of multiple doses of montelukast on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in humans. Br J Clin Pharmacol 63:339–345.
   PubMed Web of Science ®Google Scholar
• Kinberg, K.A., Hopp, R.J., Biven, R.E., Gallagher, J.C. (1994). Bone mineral density in normal and asthmatic children. J Allergy Clin Immunol 94:490–497.
   PubMed Web of Science ®Google Scholar
• Kinoshita, M., Shiraishi, T., Koga, T., Ayabe, M., Rikimaru, T., Oizumi, K. (1999). Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast. J Allergy Clin Immunol 103:534–535.
   PubMed Web of Science ®Google Scholar
• Kirkegaard, J., Mygind, N., Molgaard, F., Grahne, B., Holopainen, E., Malmberg, H., et al. (1987). Ordinary and high-dose ipratropium in perennial nonallergic rhinitis. J Allergy Clin Immunol 79:585–590.
   PubMed Web of Science ®Google Scholar
• Klossek, J.M., Laliberte, F., Laliberte, M.F., Mounedji, N., Bousquet, J. (2001). Local safety of intranasal triamcinolone acetonide: clinical and histological aspects of nasal mucosa in the long-term treatment of perennial allergic rhinitis. Rhinology 39:17–22.
   PubMed Web of Science ®Google Scholar
• Klossek, J.M., Serrano, E., Dreyfus, I., Mesbah, K., Demoly, P. (2008). [Patient preference survey on the lack of taste and odor of Nasonex nasal spray. Which impact on compliance to treatment?] Rev Laryngol Otol Rhinol (Bord) 129:35–41.
   PubMedGoogle Scholar
• Konig, P. (1988). Inhaled corticosteroids—their present and future role in the management of asthma. J Allergy Clin Immunol 82:297–306.
   PubMed Web of Science ®Google Scholar
• Konig, P., Hillman, L., Cervantes, C., Levine, C., Maloney, C., Douglass, B., et al. (1993). Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J Pediatr 122:219–226.
   PubMed Web of Science ®Google Scholar
• Kroigaard, M., Garvey, L.H., Gillberg, L., Johansson, S.G., Mosbech, H., Florvaag, E., et al. (2007). Scandinavian Clinical Practice Guidelines on the diagnosis, management, and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiol Scand 51:655–670.
   PubMed Web of Science ®Google Scholar
• Kumar, R.N., Kirking, D.L., Hass, S.L., Vinokur, A.D., Taylor, S.D., Atkinson, M.J., et al. (2007). The association of consumer expectations, experiences, and satisfaction with newly prescribed medications. Qual Life Res 16:1127–1136.
   PubMed Web of Science ®Google Scholar
• Lake, C.R., Gallant, S., Masson, E., Miller, P. (1990). Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports. Am J Med 89:195–208.
   PubMed Web of Science ®Google Scholar
• Lanier, B. (2006). Unanswered clinical questions and speculation about the role of anti-immunoglobulin E in atopic and nonatopic disease. Allergy Asthma Proc 27:S37–S42.
   PubMed Web of Science ®Google Scholar
• Lau, R. (1997). Drug interactions with zileuton. The Lancet 349:1479.
   PubMed Web of Science ®Google Scholar
• Lauerma, A.I., Kanerva, L. (1996). Contact allergy to corticosteroids. Int J Dermatol 35:92–93.
   PubMed Web of Science ®Google Scholar
• Lenhard, G., Mivsek-Music, E., Perrin-Fayolle, M., Obtulowicz, K., Secchi, A. (1997). Double-blind, randomised, placebo- controlled study of two concentrations of azelastine eye drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. Curr Med Res Opin 14:21–28.
   PubMed Web of Science ®Google Scholar
• Lervy, B., Clayton, S. (1986). Drug prescribing: some patients’ views. J R Coll Gen Pract 36:169–170.
   PubMedGoogle Scholar
• Leurs, R., Church, M.K., Taglialatela, M. (2002). H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 32:489–498.
   PubMed Web of Science ®Google Scholar
• Levy, J., Zalkinder, I., Kuperman, O., Skibin, A., Apte, R., Bearman, J.E., et al. (1995). Effect of prolonged use of inhaled steroids on the cellular immunity of children with asthma. J Allergy Clin Immunol 95:806–812.
   PubMed Web of Science ®Google Scholar
• Li, J.T., Ford, L.B., Chervinsky, P., Weisberg, S.C., Kellerman, D.J., Faulkner, K.G., et al. (1999). Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma. J Allergy Clin Immunol 103:1062–1068.
   PubMed Web of Science ®Google Scholar
• Lindgren, S., Lokshin, B., Stromquist, A., Weinberger, M., Nassif, E., McCubbin, M., et al. (1992). Does asthma or treatment with theophylline limit children’s academic performance? N Engl J Med 327:926–930.
   PubMed Web of Science ®Google Scholar
• Lindqvist, N., Holmberg, K., Pipkorn, U. (1989). Intranasally administered budesonide, a glucocorticoid, does not exert its clinical effect through vasoconstriction. Clin Otolaryngol Allied Sci 14:519–523.
   PubMed Web of Science ®Google Scholar
• Lipworth, B., Tan, S., Devlin, M., Aiken, T., Baker, R., Hendrick, D. (1998). Effects of treatment with formoterol on bronchoprotection against methacholine. Am J Med 104:431–438.
   PubMed Web of Science ®Google Scholar
• Lipworth, B.J., Struthers, A.D., McDevitt, D.G. (1989). Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. Am Rev Respir Dis 140:586–592.
   PubMed Web of Science ®Google Scholar
• Lipworth, B.J., Jackson, C.M. (2000). Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf 23:11–33.
   PubMed Web of Science ®Google Scholar
• Lubach, D., Rath, J., Kietzmann, M. (1995). Skin atrophy induced by initial continuous topical application of clobetasol followed by intermittent application. Dermatology 190:51–55.
   PubMed Web of Science ®Google Scholar
• Luengo, M., del Rio, L., Pons, F., Picado, C. (1997). Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study. Eur Respir J 10:2110–2113.
   PubMed Web of Science ®Google Scholar
• Maconochie, J.G., Minton, N.A., Chilton, J.E., Keene, O.N. (1994). Does tachyphylaxis occur to the non-pulmonary effects of salmeterol? Br J Clin Pharmacol 37:199–204.
   PubMed Web of Science ®Google Scholar
• Mahadevia, P.J., Shah, S., Leibman, C., Kleinman, L., O’Dowd, L. (2004). Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis. Ann Allergy Asthma Immunol 93:345–350.
   PubMed Web of Science ®Google Scholar
• Mak, V.H., Melchor, R., Spiro, S.G. (1992). Easy bruising as a side-effect of inhaled corticosteroids. Eur Respir J 5:1068–1074.
   PubMed Web of Science ®Google Scholar
• Malmberg, H., Grahne, B., Holopainen, E., Binder, E. (1983). Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients. Clin Otolaryngol Allied Sci 8:273–276.
   PubMed Web of Science ®Google Scholar
• Malozowski, S., Purucker, M., Worobec, A. (1999). Cushing’s syndrome induced by betamethasone nose drops. Children taking intranasal corticosteroids should be monitored for growth retardation. BMJ 318:1355.
   PubMed Web of Science ®Google Scholar
• Markson, L.E., Vollmer, W.M., Fitterman, L., O’Connor, E., Narayanan, S., Berger, M., et al. (2001). Insight into patient dissatisfaction with asthma treatment. Arch Intern Med 161:379–384.
   PubMed Web of Science ®Google Scholar
• Martin, D.E., Zussman, B.D., Everitt, D.E., Benincosa, L.J., Etheredge, R.C., Jorkasky, D.K. (1997). Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men. J Clin Psychopharmacol 17:451–459.
   PubMed Web of Science ®Google Scholar
• Mathews, D.R., McNutt, B., Okerholm, R., Flicker, M., McBride, G. (1991). Torsades de pointes occurring in association with terfenadine use. JAMA 266:2375–2376.
   PubMed Web of Science ®Google Scholar
• McCormack, P.L., Scott, L.J. (2007). Fluticasone furoate-Intranasal use in allergic rhinitis. Drugs 67:1905–1915.
   PubMed Web of Science ®Google Scholar
• McDonnell, J., Latif, M.L., Rees, E.S., Bevan, N.J., Hill, S.J. (1998). Influence of receptor number on the stimulation by salmeterol of gene transcription in CHO-K1 cells transfected with the human beta2-adrenoceptor. Br J Pharmacol 125:717–726.
   PubMed Web of Science ®Google Scholar
• McTavish, D., Sorkin, E.M. (1989). Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 38:778–800.
   PubMed Web of Science ®Google Scholar
• Meltzer, E.O. (1992). Intranasal anticholinergic therapy of rhinorrhea. J Allergy Clin Immunol 90:1055–1064.
   PubMed Web of Science ®Google Scholar
• Michalets, E.L., Williams, C.R. (2000). Drug interactions with cisapride: clinical implications. Clin Pharmacokinet 39:49–75.
   PubMed Web of Science ®Google Scholar
• Miglior, M., Scullica, L., Secchi, A.G., Negrini, A., Pezzi, P.P., Brovarone, F.V., et al. (1993). Nedocromil sodium and astemizole, alone or combined, in the treatment of seasonal allergic conjunctivitis. A multicentre double blind clinical trial. Acta Ophthalmol (Copenh) 71:73–78.
   PubMed Web of Science ®Google Scholar
• Milgrom, H., Bender, B. (1993). Current issues in the use of theophylline. Am Rev Respir Dis 147:S33–S39.
   PubMed Web of Science ®Google Scholar
• Mitchell, E.A. (1989). Is current treatment increasing asthma mortality and morbidity? Thorax 44:81–84.
   PubMed Web of Science ®Google Scholar
• Mitchell, J.L. (1999). Use of cough and cold preparations during breastfeeding. J Hum Lact. 15:347–349.
   PubMedGoogle Scholar
• Morisset, S., Rouleau, A., Ligneau, X., Gbahou, F., Tardivel-Lacombe, J., Stark, H., et al. (2000). High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 408:860–864.
   PubMed Web of Science ®Google Scholar
• Muraro, A., Roberts, G., Clark, A., Eigenmann, P.A., Halken, S., Lack, G., et al. EAACI, Task Force on Anaphylaxis in Children. (2007). The management of anaphylaxis in childhood: position paper of the European Academy of Allergology and Clinical Immunology. Allergy 62:857–871.
   PubMed Web of Science ®Google Scholar
• Murphy, R.C., Gijon, M A. (2007). Biosynthesis and metabolism of leukotrienes. Biochem J 405:379–395.
   PubMed Web of Science ®Google Scholar
• Mutch, E., Nave, R., McCracken, N., Zech, K., Williams, F.M. (2007). The role of esterases in the metabolissm: of ciclesonide to desisobutyryl-ciclesonide in human tissue. Biochem Pharmacol 73:1657–1664.
   PubMed Web of Science ®Google Scholar
• Myers, M.G. (1999). Compliance in hypertension: Why don’t patients take their pills? JAMC 160:64–65.
   PubMed Web of Science ®Google Scholar
• Nakamura, K., Yokoi, T., Kodama, T., Inoue, K., Nagashima, K., Shimada, N., et al. (1998). Oxidation of histamine H1 antagonist mequitazine is catalyzed by cytochrome P450 2D6 in human liver microsomes. J Pharmacol Exp Ther 284:437–442.
   PubMed Web of Science ®Google Scholar
• Nathan, R.A., Glass, M., Minckwitz, M.C. (1994). Inhaled ICI 204,219 blocks antigen-induced bronchoconstriction in subjects with asthma. Chest 105:483–488.
   PubMed Web of Science ®Google Scholar
• Nelson, H.S. (2003). Prospects for antihistamines in the treatment of asthma. J Allergy Clin Immunol 112:S96–S100.
   PubMedGoogle Scholar
• Newton, R., Holden, N.S. (2007). Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor? Mol Pharmacol 72:799–809.
   PubMed Web of Science ®Google Scholar
• Nicklas, R.A. (1998). The diagnosis and management of anaphylaxis. J Allergy Clin Immunol 101:S465–S528.
   PubMed Web of Science ®Google Scholar
• Nicolas, J-M., Whomsley, R., Collart, P., Roba, J. (1999). In vitro inhibition of human liver drug metabolizing enzymes by second generation antihistamines. Chemico-Biological Interactions 123:63–79.
   PubMed Web of Science ®Google Scholar
• Noubade, R., Saligrama, N., Spach, K., Del Rio, R., Blankenhorn, E.P., Kantidakis, T., et al. (2008). Autoimmune disease-associated histamine receptor H1 alleles exhibit differential protein trafficking and cell surface expression. J Immunol 180:7471–7479.
   PubMed Web of Science ®Google Scholar
• O’Connor, B.J., Aikman, S.L., Barnes, P.J. (1992). Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma. N Engl J Med 327:1204–1208.
   PubMed Web of Science ®Google Scholar
• Owens, C.A., Grundy, G.W. (1997). Focus on zileuton: the first FDA-approved agent of a new class of drugs-the 5-lipoxygenase inhibitors-for the management of asthma. Formulary 32:455–471.
   Web of Science ®Google Scholar
• Parra, S., Bond, R.A. (2007). Inverse agonism: from curiosity to accepted dogma, but is it clinically relevant? Curr Opin Pharmacol 7:146–150.
   PubMed Web of Science ®Google Scholar
• Passalacqua, G., Canonica, G.W., Bousquet, J. (2002). Structure and classification of H1-antihistamines and overview of their activities. Clin Allerg Immunol 17:65–100.
   PubMedGoogle Scholar
• Patel, K.R., Tullett, W.M. (1983). Bronchoconstriction in response to ipratropium bromide. Br Med J (Clin Res Ed) 286:1318.
   PubMed Web of Science ®Google Scholar
• Pauwels, R.A., Lofdahl, C.G., Postma, D.S., Tattersfield, A.E., O’Byrne, P., Barnes, P.J., et al. (1997). Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 337:1405–1411.
   PubMed Web of Science ®Google Scholar
• Pearce, N., Grainger, J., Atkinson, M., Crane, J., Burgess, C., Culling, C., et al. (1990). Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977–1981. Thorax 45:170–175.
   PubMed Web of Science ®Google Scholar
• Perrin-Fayolle, M., Blum, P.S., Morley, J., Grosclaude, M., Chambe, M.T. (1996). Differential responses of asthmatic airways to enantiomers of albuterol. Implications for clinical treatment of asthma. Clin Rev Allergy Immunol 14:139–147.
   PubMed Web of Science ®Google Scholar
• Persi, L., Dupin, O., Arnaud, B., Trinquand, C., Michel, F.B., Bousquet, J. (1997). Efficacy of mequitazine in comparison with placebo assessed by ocular challenge with allergen in allergic conjunctivitis. Allergy 52:451–454.
   PubMed Web of Science ®Google Scholar
• Pesco-Koplowitz, L., Hassell, A., Lee, P., Zhou, H., Hall, N., Wiesinger, B., et al. (1999). Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady-state intranasal levocabastine. J Clin Pharmacol 39:76–85.
   PubMed Web of Science ®Google Scholar
• Petruson, B., Hansson, H.A. (1982). Function and structure of the nasal mucosa after 6 weeks’ use of nose-drops. Acta Otolaryngol 94:563–569.
   PubMed Web of Science ®Google Scholar
• Pipkorn, U., Pukander, J., Suonpaa, J., Makinen, J., Lindqvist, N. (1988). Long-term safety of budesonide nasal aerosol: a 5.5-year follow-up study. Clin Allergy 18:253–259.
   PubMedGoogle Scholar
• Pollock, K., Grime, J. (2000). Patients’ views on cost effectiveness of drugs are important. Letter. BMJ 321:1292.
   PubMed Web of Science ®Google Scholar
• Porta, M., Jick, H., Habakangas, J.A. (1986). Follow-up study of pseudoephedrine users. Ann Allergy 57:340–342.
   PubMedGoogle Scholar
• Prakash, A., Lamb, H.M. (1998). Mizolastine—a review of its use in allergic rhinitis and chronic idiopathic urticaria. BioDrugs 10:41–63.
   PubMed Web of Science ®Google Scholar
• Price, K.S., Hamilton, R.G. (2007). Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy. Allergy Asthma Proc 28:313–319.
   PubMed Web of Science ®Google Scholar
• Pullerits, T., Praks, L., Skoogh, B.E., Ani, R., Lotvall, J. (1999). Randomized, placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. Am J Respir Crit Care Med 159:1814–1818.
   PubMed Web of Science ®Google Scholar
• Qureshi, F., Pestian, J., Davis, P., Zaritsky, A. (1998). Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med 339:1030–1035.
   PubMed Web of Science ®Google Scholar
• Rachelefsky, G.S., Wo, J., Adelson, J., Mickey, M.R., Spector, S.L., Katz, R.M., et al. (1986). Behavior abnormalities and poor school performance due to oral theophylline use. Pediatrics 78:1133–1138.
   PubMed Web of Science ®Google Scholar
• Ramanujan, K. (2006). Common beta-agonist inhalers more than double death rate in COPD patients, Cornell and Stanford scientists assert. Chronicle Online. June 29, 2006. Available at: http://www.news.cornell.edu/stories/June06/Salpeter.COPD.kr.html. (access date: jan 2009).
   Google Scholar
• Rankin, A.C. (1997). Non-sedating antihistamines and cardiac arrhythmia. Lancet 350:1115–1116.
   PubMed Web of Science ®Google Scholar
• Ribeiro, J.D., Toro, A.A., Baracat, E.C. (2006). Antileukotrienes in asthma and allergic rhinitis. J Pediatria 82(Suppl 5):S213–S230.
   Google Scholar
• Richards, D.M., Brogden, R.N., Heel, R.C., Speight, T.M., Avery, G.S. (1984). Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs 28:38–61.
   PubMed Web of Science ®Google Scholar
• Robinson, D.S., Geddes, D.M. (1996). Inhaled corticosteroids: benefits and risks. J Asthma 33:5–16.
   PubMed Web of Science ®Google Scholar
• Rodrigo, G., Rodrigo, C. (2002). The role of anticholinergics in acute asthma treatment: an evidence-based evaluation. Chest 21:1977–1987.
   Google Scholar
• Rook, A.J., Wilkinson, D.S. (1970). Perioral dermatitis. Br Med J 1:481.
   PubMedGoogle Scholar
• Rosenblut, A., Bardin, P.G., Muller, B., Faris, M.A., Wu, W.W., Caldwell, M.F., et al. (2007). Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. Allergy 62:1071–1077.
   PubMed Web of Science ®Google Scholar
• Roumestan, C., Henriquet, C., Bousquet, J., Mathieu, M. (2003). Fluticasone propionate and mometasone furoate have equivalent transcriptional potencies. Clin Exp Allergy 33:895–901.
   PubMed Web of Science ®Google Scholar
• Salata, J.J., Jurkiewicz, N.K., Wallace, A.A., Stupienski, R.F., 3rd., Guinosso, P.J. Jr., Lynch, J.J. Jr. (1995). Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res 76:110–119.
   PubMed Web of Science ®Google Scholar
• Salib, R.J., Howarth, P.H. (2003). Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. Drug Saf 26:863–893.
   PubMed Web of Science ®Google Scholar
• Salter, M., Biggadike, K., Matthews, J.L., West, M.R., Haase, M.V., Farrow, S.N., et al. (2007). Pharmacological properties of the enhanced- affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease. Am J Physiol Lung Cell Mol Physiol 293:L660–L667.
   PubMed Web of Science ®Google Scholar
• Scadding, G.K., Durham, S.R., Mirakian, R., Jones, N.S., Leech, S.C., Farooque, S., et al. (2008). BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy 38:19–42.
   PubMed Web of Science ®Google Scholar
• Schmidt, B.M.W., Timmer, W., Georgens, A.C., Hilt, M., Mattinger, C., Wurst, W., et al. (1999). The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis. J Clin Pharmacol 39:1062–1069.
   PubMed Web of Science ®Google Scholar
• Schuller, D.E., Selcow, J.E., Joos, T.H., Hannaway, P.J., Hirsch, S.R., Schwartz, H.J., et al. (1990). A multicenter trial of nedocromil sodium, 1% nasal solution, compared with cromolyn sodium, and placebo in ragweed seasonal allergic rhinitis. J Allergy Clin Immunol 86:554–561.
   PubMed Web of Science ®Google Scholar
• Sessler, C.N. (1990). Theophylline toxicity: clinical features of 116 consecutive cases. Am J Med 88:567–576.
   PubMed Web of Science ®Google Scholar
• Sessler, C.N., Cohen, M.D. (1990). Cardiac arrhythmias during theophylline toxicity. A prospective continuous electrocardiographic study. Chest 98:672–678.
   PubMed Web of Science ®Google Scholar
• Settipane, G.A., Klein, D.E., Boyd, G.K., Sturam, J.H., Freye, H.B., Weltman, J.K. (1979). Adverse reactions to cromolyn. JAMA 241:811–813.
   PubMed Web of Science ®Google Scholar
• Shader, R.I., Granda, B.W., von Moltke, LL., Giancarlo, G.M., Greenblatt, D.J. (1999). Inhibition of human cytochrome P450 isoforms in vitro by zafirlukast. Biopharm Drug Dispos 20:385–388.
   PubMed Web of Science ®Google Scholar
• Shannon, M. (1993). Predictors of major toxicity after theophylline overdose. Ann Intern Med 119:1161–1167.
   PubMed Web of Science ®Google Scholar
• Shannon, M. (1999). Life-threatening events after theophylline overdose: a 10-year prospective analysis. Arch Intern Med 159:989–994.
   PubMed Web of Science ®Google Scholar
• Sheikh, J. (2008). Rhinitis, Allergic. The Medscape Journal May 9. [www.emedecine.medscape.com ]
   Google Scholar
• Shen, Howard (2008). Illustrated Pharmacology Memory Cards: PharMnemonics. Minireview LLC, Twinsburg. pp. 4. ISBN 1-59541-101-1.
   Google Scholar
• Simons, F.E. (1987). Anticholinergic drugs and the airways: “time future contained in time past.” J Allergy Clin Immunol 80:239–242.
   PubMed Web of Science ®Google Scholar
• Simons, F.E., Reggin, J.D., Roberts, J.R., Simons, K.J. (1994). Benefit/risk ratio of the antihistamines (H1-receptor antagonists) terfenadine and chlorpheniramine in children. J Pediatr 124:979–983.
   PubMed Web of Science ®Google Scholar
• Simons, F.E. (2004). Advances in H1 antihistamines. N Engl J Med 351:2203–2217.
   PubMed Web of Science ®Google Scholar
• Simons, F.E. (2008). Emergency treatment of anaphylaxis. BMJ 336:1141–1142.
   PubMed Web of Science ®Google Scholar
• Skoner, D. (2002). Update of growth effects of inhaled and intranasal corticosteroids. Curr Opin Allergy Clin Immunol 2:7–10.
   PubMedGoogle Scholar
• Skoner, D.P., Gentile, D.A., Doyle, W.J. (2008). Effect on growth of long-term treatment with intranasal triamcinolone acetonide aqueous in children with allergic rhinitis. Ann Allergy Asthma Immunol 101:431–436.
   PubMed Web of Science ®Google Scholar
• Smith, M.J., Hodson, M.E. (1983a). Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax 38:676–681.
   PubMed Web of Science ®Google Scholar
• Smith, M.J., Hodson, M.E. (1983b). High-dose beclomethasone inhaler in the treatment of asthma. Lancet 1:265–269.
   PubMed Web of Science ®Google Scholar
• Smyllie, H.C., Connolly, C.K. (1968). Incidence of serious complications of corticosteroid therapy in respiratory disease. A retrospective survey of patients in the Brompton hospital. Thorax 23:571–581.
   PubMed Web of Science ®Google Scholar
• Snyder, S.H., Snowman, A M. (1987). Receptor effects of cetirizine. Ann Allergy 59:4–8.
   PubMedGoogle Scholar
• Soar, J., Pumphrey, R., Cant, A., Clarke, S., Corbett, A., Dawson, P., et al.; Working, Group of the Resuscitation Council (UK). (2008). Emergency treatment of anaphylactic reactions—guidelines for healthcare providers. Resuscitation 77:157–169.
   PubMed Web of Science ®Google Scholar
• Solans, A., Carbo, M., Peña, J., Nadal, T., Izquierdo, I., Merlos, M. (2007). Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: a single-dose, randomized, open-label, two-way crossover study. Clin Ther 29:900–908.
   PubMed Web of Science ®Google Scholar
• Spahn, J.D., Szefler, S.J. (2002). Childhood asthma: new insights into management. J Allergy Clin Immunol 109:3–13.
   PubMed Web of Science ®Google Scholar
• Spector, S.L. (2001). Safety of antileukotriene agents in asthma management. Ann Allergy Asthma Immunol 86:18–23.
   PubMed Web of Science ®Google Scholar
• Spitzer, W.O. (1992). The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 326:501–506.
   PubMed Web of Science ®Google Scholar
• Stalder, J.F., Fleury, M., Sourisse, M., Rostin, M., Pheline, F., Litoux, P. (1994). Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol 131:536–540.
   PubMed Web of Science ®Google Scholar
• Stead, R.J., Cooke, N.J. (1989). Adverse effects of inhaled corticosteroids. BMJ 298:403–404.
   PubMed Web of Science ®Google Scholar
• Storms, W.W. (2004). Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. J Allergy Clin Immunol 114:S146–S153.
   PubMed Web of Science ®Google Scholar
• Strolin Benedetti, M., Whomsley, R., Baltes, E. (2006). Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics. Expert Opin. Drug Metab. Toxicol 2:895–921.
   PubMed Web of Science ®Google Scholar
• Suessbrich, H., Waldegger, S., Lang, F., Busch, A.E. (1996). Blockade of HERG channels expressed in xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett 385:77–80.
   PubMed Web of Science ®Google Scholar
• Suttle, A.B., Vargo, D.L., Wilkinson, L.A., Birmingham, B.K., Lasseter, K. (1997). Effect of zafirlukast on the pharmacokinetics of R- and S-warfarin in healthy men. Clin Pharmacol Ther 61:186.
   Google Scholar
• Szefler, S.J. (2001). Pharmacokinetics of intranasal corticosteroids. J Allergy Clin Immunol 108:S26–S31.
   PubMed Web of Science ®Google Scholar
• Taglialatela, M., Timmerman, H., Annunziato, L. (2000). Cardiotoxic potential and CNS effects of first-generation antihistamines. Trends Pharmacol Sci 21:52–56.
   PubMed Web of Science ®Google Scholar
• Taverner, D., Latte, G.J. (2007). Nasal decongestants for the common cold. Cochrane Database of Systematic Reviews Issue 1, Art. No.: CD001953. DOI: 10.1002/14651858.CD001953.pub3.
   Google Scholar
• Thomas, S.H., Clark, K.L., Allen, R., Smith, S.E. (1991). A comparison of the cardiovascular effects of phenylpropanolamine and phenylephrine containing proprietary cold remedies. Br J Clin Pharmacol 32:705–711.
   PubMed Web of Science ®Google Scholar
• Thompson, M.D., Siminovitch, K.A., Cole, D.E. (2008). G protein–coupled receptor pharmacogenetics. Meth Mol Biol 448:139–185.
   PubMedGoogle Scholar
• Timmerman, H. (1992). Factors involved in the incidence of central nervous system effects of H1-blockers. In: Church, M.K., Rihoux, J.P. (eds). Therapeutic index of antihistamines. Lewiston, New-York: Hogrefe and Huber (pp 19–31 ).
   Google Scholar
• Toogood, J.H., Jennings, B., Greenway, R.W., Chuang, L. (1980). Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol 65:145–153.
   PubMed Web of Science ®Google Scholar
• Tuggey, J.M., Hosker, H.S. (2000). Churg-Strauss syndrome associated with montelukast therapy. Thorax 55:805–806.
   PubMed Web of Science ®Google Scholar
• Turker, S., Onur, E., Ozer, Y. (2004). Nasal route and drug delivery systems. Pharm World Sci 26:137–142.
   PubMed Web of Science ®Google Scholar
• Turktas, I., Ozkaya, O., Bostanci, I., Bideci, A., Cinaz, P. (2001). Safety of inhaled corticosteroid therapy in young children with asthma. Ann Allergy Asthma Immunol 86:649–654.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research(CBER). (1997). Guidance for Industry Postmarketing Adverse Experience Reporting for Human Drug and Licensed Biological Products: Clarification of What to Report. US FDA publication Rockville, MD. Available at: http://www.fda.gov/cder/guidance/1830fN1.pdf (access date: jan 2009).
   Google Scholar
• U.S. Department of Health and Human Services, Food and Drug Administration, Division of Dockets Management. (2000). Guidance on safety pharmacology studies for human pharmaceuticals. US FDA publication Rockville, MD. Available at: www.fda.gov/ohrms/dockets/98fr/00d1407gd.pdf (access date: jan 2009).
   Google Scholar
• Valotis, A., Högger, P. (2007). Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate. Respir Res 8:54.
   PubMed Web of Science ®Google Scholar
• Van Cauwenberge, P., Watelet, J.B., Verhoye, C., Wang, D., Bachert, C. (1999). The clinical expression of allergy in the nose. Allergy 54:93–102.
   PubMed Web of Science ®Google Scholar
• Van Cauwenberge, P., Bachert, C., Passalacqua, G., Bousquet, J., Canonica, G.W., Durham, S.R., et al. (2000). Consensus statement on the treatment of allergic rhinitis, European Academy of Allergology and Clinical Immunology. Allergy 55:116–134.
   PubMed Web of Science ®Google Scholar
• Van Hoecke, H., Vandenbulcke, L., Van Cauwenberge, P. (2007). Histamine and leukotriene receptor antagonism in the treatment of allergic rhinitis—an update. Drugs 67:2717–2726.
   PubMed Web of Science ®Google Scholar
• Van Metre, T.E. Jr. (1969). Adverse effects of inhalation of excessive amounts of nebulized isoproterenol in status asthmaticus. J Allergy 43:101–113.
   PubMedGoogle Scholar
• Vuurman, E.F., van Veggel, L.M., Sanders, R.L., Muntjewerff, N.D., O’Hanlon, J.F. (1996). Effects of semprex-D and diphenhydramine on learning in young adults with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 76:247–252.
   PubMed Web of Science ®Google Scholar
• Vuurman, E.F., van Veggel, L.M., Uiterwijk, M.M., Leutner, D., O’Hanlon, J.F. (1993). Seasonal allergic rhinitis and antihistamine effects on children’s learning. Ann Allergy 71:121–126.
   PubMedGoogle Scholar
• Walker, S.R., Richards, A.J., Paterson, J.W. (1971). The absorption, excretion, and metabolism of disodium (14C)cromoglycate in man. Biochem J 125:27P.
   PubMed Web of Science ®Google Scholar
• Walsky, R.L., Scott Obach, R, Gaman, E.A., Gleeson, J-P.R., Proctor, W.R. (2005). Selective inhibition of human cytochrome P450 2C8 by montelukast. Drug Meta. Dispos 33:413–418.
   PubMed Web of Science ®Google Scholar
• Warner, J.O., Naspitz, C.K. (1998). Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group. Pediatr Pulmonol 25:1–17.
   PubMed Web of Science ®Google Scholar
• Watelet, J.B., Van Zele, T., Gjomarkaj, M., Canonica, G.W., Dahlen, S.E., Fokkens, W., et al. GA(2)LEN Workpackage Members 2.7. (2006). Tissue remodelling in upper airways: where is the link with lower airway remodelling? Allergy 61:1249–1258.
   PubMed Web of Science ®Google Scholar
• Wechsler, M.E., Drazen, J.M. (1999). Zafirlukast and Churg-Strauss syndrome. Chest 116:266–267.
   PubMed Web of Science ®Google Scholar
• Wechsler, M.E., Finn, D., Gunawardena, D., Westlake, R., Barker, A., Haranath, S.P., et al. (2000). Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 117:708–713.
   PubMed Web of Science ®Google Scholar
• Wechsler, M.E., Garpestad, E., Flier, S.R., Kocher, O., Weiland, D.A., Polito, A.J., et al. (1998). Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA 279:455–457.
   PubMed Web of Science ®Google Scholar
• Weiland, G.A., Molinoff, P.B. (1981). Quantitative analysis of drug- receptor interactions: I. Determination of kinetic and equilibrium properties. Life Sci 29:313–330.
   PubMed Web of Science ®Google Scholar
• Weinberger, M. (1975). Letter: use of theophylline in asthma. N Engl J Med 293:409.
   PubMed Web of Science ®Google Scholar
• Weinberger, M. (1994). Therapeutic indications and rationale for theophylline in the management of asthma. Allergy Proc 15:275–282.
   PubMedGoogle Scholar
• Weinberger, M., Hendeles, L. (1996). Theophylline in asthma. N Engl J Med 334:1380–1388.
   PubMed Web of Science ®Google Scholar
• Weiner, J.M., Abramson, M.J., Puy, R.M. (1998). Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 317:1624–1629.
   PubMed Web of Science ®Google Scholar
• Weller, P.F., Plaut, M., Taggart, V., Trontell, A. (2001). The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. J Allergy Clin Immunol 108:175–183.
   PubMedGoogle Scholar
• Whomsley, R., Strolin Benedetti, M. (2005). Development of new H1 antihistamines: the importance of pharmacokinetics in the evaluation of safe and therapeutically effective agents. Curr Med Chem Anti-inflam Anti-allergy agents 4:451–464.
   Google Scholar
• Wilkinson, D.S., Kirton, V., Wilkinson, J.D. (1979). Perioral dermatitis: a 12-year review. Br J Dermatol 101:245–257.
   PubMed Web of Science ®Google Scholar
• Wilson, A.M., O’Byrne, P.M., Parameswaran, K. (2004). Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. Am J Med 116:338–344.
   PubMed Web of Science ®Google Scholar
• Wiseman, L.R., Faulds, D. (1996). Ebastine—a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders. Drugs 51:260–277.
   PubMed Web of Science ®Google Scholar
• Woelfle, J., Zielen, S., Lentze, M.J. (2000). Unilateral fixed dilated pupil in an infant after inhalation of nebulized ipratropium bromide. J Pediatr 136:423–424.
   PubMed Web of Science ®Google Scholar
• Wolthers, O.D. (2000a). Impact of inhaled and intranasal corticosteroids on the growth of children. BioDrugs 13:347–357.
   PubMed Web of Science ®Google Scholar
• Wolthers, O.D. (2000b). Systemic activity versus systemic adverse effects of nasal glucocorticoids in the treatment of allergic rhinitis. Acta Paediatr 89:1158–1161.
   PubMed Web of Science ®Google Scholar
• Wolthers, O.D., Heuck, C. (1998). Differential effects of inhaled budesonide on serum osteocalcin in children and adolescents with asthma. Pediatr Allergy Immunol 9:150–155.
   PubMed Web of Science ®Google Scholar
• Wolthers, O.D., Pedersen, S. (1991). Growth of asthmatic children during treatment with budesonide: a double-blind trial. BMJ 303:163–165.
   PubMed Web of Science ®Google Scholar
• Wolthers, O.D., Riis, B.J., Pedersen, S. (1993). Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonide. Pediatr Pulmonol 16:341–346.
   PubMed Web of Science ®Google Scholar
• Wong, C.A., Walsh, L.J., Smith, C.J., Wisniewski, A.F., Lewis, S.A., Hubbard, R., et al. (2000). Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 355:1399–1403.
   PubMed Web of Science ®Google Scholar
• Wood, C.C., Fireman, P., Grossman, J., Wecker, M., MacGregor, T. (1995). Product characteristics and pharmacokinetics of intranasal ipratropium bromide. J Allergy Clin Immunol 95:1111–1116.
   PubMed Web of Science ®Google Scholar
• Woosley, R.L. (1996). Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol 36:233–252.
   PubMed Web of Science ®Google Scholar
• Woosley, R.L., Chen, Y., Freiman, J.P., Gillis, R.A. (1993). Mechanism of the cardiotoxic actions of terfenadine. JAMA 269:1532–1536.
   PubMed Web of Science ®Google Scholar
• Yamauchi, K., Sekizawa, K., Suzuki, H., Nakazawa, H., Ohkawara, Y., Katayose, D., et al. (1994). Structure and function of human histamine N-methyltransferase: critical enzyme in histamine metabolism in airway. Am J Physiol 267:L342–L349.
   PubMed Web of Science ®Google Scholar
• Yoshimi, A., Hashizume, H., Kitagawa, M., Nishimura, K., Kakeya, N. (1992). Characteristics of 1,3-bis-(2-ethoxycarbonylchromon-5-yloxy)-2-((S)- lysyloxy)propane dihydrochloride (N-556), a prodrug for the oral delivery of disodium cromoglycate, in absorption and excretion in rats and rabbits. J Pharmacobiodyn 15:681–686.
   PubMedGoogle Scholar
• Yumibe, N., Huie, K., Chen, K-J., Snow, M., Clement, R.P., Cayen, M.N. (1996). Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Biochem Pharmacol 51:165–172.
   PubMed Web of Science ®Google Scholar
• Zaritsky, A., Qureshi, F. (1999). Ipratropium does indeed reduce admissions to hospital with severe asthma. BMJ 318:738.
   PubMed Web of Science ®Google Scholar
• Zussman, B.D., Benincosa, L.J., Webber, D.M., Clark, D.J., Cowley, H., Kelly, J., et al. (2001a). An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteers. J Clin Pharmacol 41:950–958.
   PubMed Web of Science ®Google Scholar
• Zussman, B.D., Davie, C.C., Kelly, J., Murdoch, R.D., Clark, D.J., Schofield, J.P., et al. (2001). Bioavailability of the oral selective phosphodiesterase 4 inhibitor cilomilast. Pharmacotherapy 21:653–660.
   PubMed Web of Science ®Google Scholar
• No authors listed. (2007). Omal Zumab: New drug. Asthma: too many unknowns for an anti-Ige. Prescribe Int 16:179–182.
   PubMedGoogle Scholar